Corient Capital Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.01M |
| 2 |
Microsoft
MSFT
|
+$1.78M |
| 3 |
Eaton
ETN
|
+$1.18M |
| 4 |
Danaher
DHR
|
+$1.12M |
| 5 |
Huntington Bancshares
HBAN
|
+$1.09M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.97M |
| 2 |
Vanguard S&P 500 Growth ETF
VOOG
|
+$1.15M |
| 3 |
Vanguard S&P 500 Value ETF
VOOV
|
+$897K |
| 4 |
XEC
CIMAREX ENERGY CO
XEC
|
+$886K |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$822K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.98% |
| 2 | Financials | 12.65% |
| 3 | Healthcare | 10.27% |
| 4 | Industrials | 8.01% |
| 5 | Consumer Discretionary | 7.13% |
Similar funds
Corient Capital Partners's Q4 2019 Portfolio in Review
As of Q4 2019, Corient Capital Partners held 498 positions worth $787M, up 11% from $706M the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Corient Capital Partners deployed $26.5M of net new capital in Q4 2019, opening 39 new positions and adding to 268 existing holdings. Its largest new stake was Huntington Bancshares: 74,119 shares worth $1.12M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Vanguard S&P 500 Growth ETF, an estimated $1.15M trimmed.
- Corient Capital Partners's largest Q4 2019 buy was Huntington Bancshares: 74,119 shares worth $1.12M.
- Corient Capital Partners added most to Bristol-Myers Squibb in Q4 2019, an estimated $2.01M increase.
- Corient Capital Partners's biggest Q4 2019 reduction was Vanguard S&P 500 Growth ETF, cutting an estimated $1.15M.
- Corient Capital Partners fully exited Celgene Corp in Q4 2019, selling an estimated $1.97M.
- Corient Capital Partners's ten largest holdings make up 27% of its $787M portfolio in Q4 2019.
- Corient Capital Partners opened 39 new positions and closed 31 in Q4 2019.
- Corient Capital Partners's portfolio value rose 11% quarter-over-quarter to $787M.
Based on Corient Capital Partners's 13F filing for Q4 2019, filed 4 Feb 2020.